Indefinite Delivery Contract HHSN272201700034I

Award Date 7/13/17
Last Date to Order 7/13/24
Ultimate Awardee
Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, has awarded a single-award Indefinite Delivery Contract (IDC) valued at $146.3 million to the University of Cincinnati. The contract, titled "Pre-Clinical Models of Infectious Diseases - Task Area A," has an ordering period through July 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop, refine, and employ...
The University of Cincinnati Sponsored Research Services Division holds a multiple award IDV from the National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development to conduct contraceptive clinical trials and develop related research protocols. With a potential value of $5 million over five years and no set-aside used, the IDV aims to provide assistance with contraceptive clinical trials network activities through finalizing protocols, gaining...
The National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDV) valued at $5,000,000 to the University of Cincinnati's Sponsored Research Services Division. This 7-year IDV facilitates the conduct of clinical trials related to contraceptive development, gynecologic conditions, and associated protocol development. Under this IDV, two task orders have been issued to the University of...
The Indefinite Delivery Contract (IDC) 75N93024D00028 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Tennessee, a non-profit educational institution. The $146.3M contract has an ordering period ending in July 2031 and covers the development and use of animal and animal replacement models to evaluate candidate countermeasures (e.g., therapeutics, vaccines,...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Emory University, a private research university. The contract has a ceiling value of $146,300,000 and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with the capability to develop, refine, and employ small animal models, non-human primate models, animal...
This Indefinite Delivery Contract (IDC), awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, is focused on providing pre-clinical models of infectious diseases. The $146.3 million single-award contract was granted to The Regents of the University of California, San Francisco (UCSF), a U.S. state government and educational institution, for a period of performance from July 2024 through April 2030. The contract aims to develop and refine animal and...
The indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Georgia Research Foundation, Inc. (UGA Research Foundation), a non-profit organization. The single-award IDC has a ceiling value of $146.3 million over 7 years and focuses on developing and employing animal and animal replacement models of infectious diseases to support NIAID's pandemic preparedness...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Duke University's Office of Research Administration Division as the prime contractor. The $20,000,000 IDC falls under the NIAID Animal Models of Infectious Diseases 2010-2017 multiple-award IDIQ contract vehicle and does not have any set-aside designations. Under this IDC, Duke University will...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Health and Human Services' National Institute of Child Health and Human Development to the University of Cincinnati, a public research institution. The $3.43M contract, which has a period of performance through March 2011, is for the provision of blood and blood products through the Hoxworth Blood Center. The IDC has facilitated the award of several firm-fixed price delivery orders over the years, ranging from $120,000...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB) to provide preclinical models and services for the development and evaluation of medical countermeasures against infectious diseases. The $146.3M single-award IDC has a 7-year ordering period and covers four task areas: (A) small animal...

This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to the University of Cincinnati. The $40 million, multiple-award IDC is intended to support pre-clinical research models of infectious diseases from 2017 to 2024.

Under this IDC, the University of Cincinnati has been issued two task orders to date. The first task order, valued at $1,908.66, supports the kickoff and initial base funding for the OBRA-15 base IDIQ contract. The second task order, with an unspecified value, will facilitate the Contraceptive Clinical Trials Network activities from 2020-2027 and the finalization of protocols, regulatory approval, and commencement of recruitment for an Ovaprene vaginal device clinical trial from 2023-2024. As the prime contractor, the University of Cincinnati will execute this broad clinical research agenda on behalf of NIAID.

Generated 7/19/24, 9:05 AM